United Kingdom: English High Court considers parallel imports

The High Court has held that pharmaceutical product Epanutin must be rebranded in order to gain access to the market. The decision provides a useful review of UK law on the parallel import of pharmaceutical products

Unlock unlimited access to all WTR content